Objective: Understanding the pathophysiological processes of osteoarthritis (OA) require adequate model systems. Although different in vitro or in vivo models have been described, further comprehensive approaches are needed to study specific parts of the disease. This study aimed to combine in vitro and in silico modeling to describe cellular and matrix-related changes during the early phase of OA. We developed an in vitro OA model based on scaffoldfree cartilage-like constructs (SFCCs), which was mathematically modeled using a partial differential equation (PDE) system to resemble the processes during the onset of OA.
Introduction
The pathogenesis of osteoarthritis (OA) has not been fully understood so far, partly due to the lack of an optimal model system which sufficiently incorporates all aspects of the disease [1, 2] . A vast variety of in vivo, ex vivo, in vitro and (to some extent) in silico models for OA already exists, and these all try to mimic the main features of OA pathophysiology including the degradation of extracellular matrix (ECM), inflammation and alterations in cell metabolism, viability and differentiation [3] [4] [5] .
In vivo OA models are crucial for translational research, but mainly make use of small rodents, especially mice, although these species show significant differences in articular cartilage anatomy, loading conditions and life span [6, 7] . Thus, in vitro models represent an important tool to investigate the mechanisms involved in the pathogenesis of OA and to examine possible therapeutic values. Model systems include monolayer cultures with cell lines or primary chondrocytes, co-cultures, 3D-cultures and cartilage explants from either humans or animals [8] . However, a major challenge is the source of primary chondrocytes or explants, since healthy human cartilage samples are rare, and thus sample collection is mainly undertaken from total joint replacement surgeries. Independent of the cell source, it is a consensus that the 3D cultivation of primary chondrocytes resembles the in vivo situation more closely. Most 3D culture systems involve a scaffold to provide the cells with a predetermined structure where their distinct effects on the cells are often not considered. Recent developments aim to establish scaffold-free tissue engineered cartilage mainly from human chondrocytes which could serve as a promising approach to cartilage repair in vivo, as well as an excellent in vitro model, since ECM formation and degradation can be evaluated without the interference of a scaffold [9] [10] [11] .
In addition to biological models, in silico modeling offers a powerful tool to bring clarity to the processes that evolve during in vitro or in vivo modeling [12, 13] . Few studies have been performed so far to obtain parameters for in vitro modeling, although a combination of biological data with mathematical modeling promises to accelerate translation in OA research [14] [15] [16] . Catt et al. describe a partial differential equation (PDE) model of cartilage with a focus on the production of ECM and the growth of chondrocytes synergistically leading to tissue expansion [15] . Moreover, Kar et al. investigate cartilage degradation induced by interleukin-1β (IL-1β) using a PDE model based on data from the literature together with existing experimental data to calibrate their model [16] . In contrast, Baker et al. use an ordinary differential equation (ODE) system to describe the interaction of anti-inflammatory cytokines, proteinases and fibronectin in arthritic cartilage [17] . Since biomechanical influences are of utmost interest, several approaches here have already been used, and these include model arthritic cartilage under cyclic compressive loading or a combining of inflammation and biomechanics [18, 19] .
However, most of the above-mentioned models and approaches have been developed almost independently from experiments lacking the combination of in vitro and in silico modeling processes. Thus, the objective of our study was to develop a human in vitro OA model based on engineered tissue and scaffold-free cartilage-like constructs (SFCCs) sourcing from human mesenchymal stromal cells (hMSCs). These SFCCs were mathematically modeled in parallel based on PDEs resembling the matrix degradation processes during the early phase of OA. 
Material & Methods

General study design
hMSC isolation and expansion
Human mesenchymal stromal cells (hMSCs) were obtained from human femoral bone marrow of patients undergoing hip arthroplasty (provided by the Centre for Musculoskeletal Surgery, Charité -Universitätsmedizin Berlin and distributed by the "Tissue Harvesting" Core Facility of the Berlin Brandenburg Centre for Regenerative Therapies, Berlin, Germany). All protocols were approved by the Charité -Universitätsmedizin Ethics Committee and performed according to the Helsinki Declaration (ethical approval EA1/012/13). Donor information is summarized in Table 1 . hMSCs were cultivated in DMEM GlutaMAX™ Medium (Thermo Fisher Scientific, MA) with 20 % (v/v) StemMACS™ (Miltenyi Biotech, Germany), 10 % (v/v) fetal calf serum (FCS) (Thermo Fisher Scientific, MA), 100 units/ml penicillin and 0.1 mg/ml streptomycin (Thermo Fisher Scientific, MA) at a temperature of 37 °C in 5 % CO2 atmosphere. hMSCs were cultured separately for each donor and characterized by flow cytometry (CD90 + , CD105 + , CD73 + , CD14 -, CD20 -, CD34 -, CD45 -, HLA-DR -) as well as osteogenic, adipogenic and chondrogenic differentiation assays. Only cells successfully passing the characterization were further cultivated up to passages 3-5. 
Generation of SFCCs and experimental setup
SFCCs were produced based on a patented protocol [20] . In short, around 10-15 million hMSCs were transferred into a 3D state via centrifugation and self-assembly followed by maturation for 3 to 4 weeks applying biomechanical forces until reaching cartilage-like stiffness [21] . In advance of the experiments, SFCCs were cultured for 4 weeks in DMEM GlutaMAX™ Medium, supplemented with 10 % (v/v) FCS, 100 units/ml penicillin and 0.1 mg/ml streptomycin (all from Thermo Fisher Scientific, MA) and 9.39 mg/l ascorbic acid (Sigma-Aldrich, MO); in the following, this is referred to as 'standard medium'. In a first step, SFCCs were cultivated under cytokine-free conditions and samples were taken on days 0, 7, 14 and 21 (n = 3 per time point). Secondly, to resemble the proinflammatory state that has been described in patients with early OA, stimulation was performed using standard medium supplemented with 50 ng/ml recombinant human IL-1β (2 x 10 8 IU/mg) and 100 ng/ml recombinant human tumor necrosis factor alpha (TNFα) (2 x 10 7 IU/mg; both from ImmunoTools, Germany). Samples of cytokine stimulated SFCCs (STIM) and controls (CTL) were taken on day 21 (n = 9 with triplicates of 3 different donors). A subset of cytokine stimulated SFCCs was further cultivated for 21 more days under cytokine free conditions to evaluate whether regeneration might occur (REG) (n = 9 with triplicates of 3 different donors). SFCCs from each donor were randomized into groups and analysis was performed in a blinded fashion by numbering samples at random.
Histological staining and immunofluorescence
Samples for histological analysis were first fixed in 4 % paraformaldehyde (PFA) for 6 h and subsequently treated with 10%, 20% and then 30% glucose solution, each for 24 h. After fixation, samples were cryo-embedded in SCEM embedding medium and cryo-sections of 8µm thickness were prepared using cryofilms (Sectionlab, Japan). Prior to each histological and immunohistochemical staining, procedure slices were dried for 20 min at room temperature.
H&E and Alcian blue staining
Hematoxylin and eosin (H&E) staining was performed according to the following protocol:
fixation with 4% PFA (10 min), washing with distilled water (5 min 
Immunofluorescence staining -MMP1 and MMP13
Immunofluorescence staining was used to quantify the MMPs. First of all, the slides were air- min. After air bubble-free covering with FluoroMount covering medium, microscopic evaluation was performed with the fluorescence microscope BZ-9000A (Keyence, Germany) using the DAPI and TRITC channels. Image analysis was performed using ImageJ. Determining the cell number the find maxima tool was used for the DAPI image, whereas the area of MMP positive signals was measured using the color threshold tool.
Histomorphometry
Histomorphometry was performed using FIJI ImageJ 1.52i [22, 23] . H&E stained sections were used to analyze the cell count per area and cell distribution within the SFCCs. The cell count per tissue area (cells/mm 2 ) was identified from HE overview pictures of each SFCC with 50x magnification using a modified color deconvolution method [24] (for additional detail information see Fig. 2 and Table 2 ). First, a free hand selection tool was used to define the region of interest (ROI) for the section outline representing the total area (Tt.A.) of the section. 
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Figure 2: Pipeline for histomorphometric analysis. (A)
Histomorphometric analysis for cell count per area using a modified color deconvolution method. A 50x magnification overview image of an H&E stained section was taken. The section outline was defined using the Polygonal Selection tool in ImageJ (1) . In order to subtract the background (or gap area) the Color Threshold tool was utilized (2) . Next, the Color Deconvolution plugin (3) was used to obtain the hematoxylin color channel only in which the cell nuclei could be identified using a threshold for brightness (4) . Particle analysis could then be performed based on the binary image attained in the previous step to obtain the cell count per area [cells/mm 2 ].
(B) For further analysis, the 'Total Area' was further divided into an 'Outer Area' by scaling the region of interest (ROI) for 'Total Area' to 0.95 for X-and Y-axes. The remaining 'Core Area' was then divided into an 'Outer Core Area' and an 'Inner Core Area' by scaling the ROI for the 'Core Area' by 0.5 for the X-and Y-axes. Gen symbol Sequence of forward primer Sequence of reverse primer
RNA isolation, cDNA synthesis and qPCR
EF1A 5' -GTTGATATGGTTCCTGGCAAGC -3' 5' -TTGCCAGCTCCAGCAGCCT -3' COL1A1 5' -AGGTCACAGGTCTCGAAAAAGC -3' 5' -CTCCTGACGCACGGCC -3' COL2A1 5' -GTGGGGCAAGACTGTTATCG -3' 5' -AGGTCAGGTCAGCCATTCAG -3' COL10A1 5' -CCAGCACGCAGAATCCATCT -3' 5' -TATGCCTGTGGGCATTTGGT -3' ACAN 5' -AACGCAGACTACAGAAGCGG -3' 5' -GGCGGACAAATTAGATGCGG -3' MMP1 5' -CTCTGGAGTAATGTCACACCTCT -3' 5' -TGTTGGTCCACCTTTCATCTTC -3' MMP3 5' -ATCCTACTGTTGCTGTGCGT -3' 5' -CATCACCTCCAGAGTGTCGG -3' MMP13 5' -TCCTGATGTGGGTGAATACAATG -3' 5' -GCCATCGTGAAGTCTGGTAAAAT -3' TNF 5' -GTCTCCTACCAGACCAAG -3' 5' -CAAAGTAGACCCTGCCCAGACTC -3' IL1B 5' -AGCTACGAATCTCCGACCAC -3' 5' -CGTTATCCCATGTGTCGAAGAA -3' IL8 5' -GAATGGGTTTGCTAGAATGTGATA -3' 5' -CAGACTAGGGTTGCCAGATTTAAC -3' IL6 5' -TACCCCCAGGAGAAGATTCC -3' 5' -TTTTCTGCCAGTGCCTCTTT -3'
RNA isolation from human cartilage
Human cartilage was collected from femoral condyles taken during total knee replacement surgeries (ethical approval EA1/012/13). Cartilage was harvested from areas as unaffected as possible and transferred to RNAlater (QIAGEN, Germany) for 1 h at 4 °C: Before cryoconservation at -80 °C the RNAlater was removed completely. Cartilage samples were cryopulverized (59012N, Biospec, Bartlesville, OK) and gently resuspended in TriFast™ (VWR, Germany) mixed with 1-bromo-3-chloropropane (Sigma Aldrich, MO). Centrifugation was performed after 10 min of incubation for 10 min at 10.000 x g. The top aqueous phase was further used for RNA isolation using the RNeasy Mini Kit (QIAGEN, Germany) according to the protocols provided. cDNA synthesis and qPCR were performed as described above.
Statistical analysis
Statistical analysis was performed with the GraphPad Prism V.8 software. Quantitative data is shown as mean ± SEM for gene expression data and mean ± SD for all other data. Since the number of samples was small and Gaussian distribution was not assumed, we used the Image analysis was carried out blinded for treatment groups. Important numbers and adjusted p-values are stated either in the text or in the graphs.
In silico model generation
To 
Results
SFCCs show stable cartilage-like phenotype over 3 weeks
To evaluate the cellular and matrix composition of the SFCCs under non-inflammatory conditions, samples were taken weekly over a period of 3 weeks (d0, 7, 14, 21; n = 3; one sample per donor at each time point). Alcian blue staining for SFCC sections was performed at all time points and revealed the constant presence of glycosaminoglycans (GAGs) (Fig. 3A) .
Hematoxylin & eosin (H&E) staining showed no obvious morphological changes in cell and matrix composition between time points (Fig. 3A) . Cell density decreased over the period of 3 weeks from a mean cell density of 1.378 ± 694 cells/mm 2 at d0 to a mean cell density of 505 ± 268 cells/mm 2 at d21 (Fig. 3B ). In addition, histomorphometry revealed a higher cell count in the outer area (Ot.A.) than it did in the total area (Tt.A.) ( Fig. 2 and Table 2 ), indicating a spatial arrangement of cells within the construct (Fig. 3B ). Collagen I (Col-1) was more abundantly present within the constructs compared to Col-2 although no difference could be identified between time points (Fig. 3C ). qPCR analyses revealed the mRNA expression of the cartilage specific markers COL2A1 and ACAN, although COL1A1 expression was higher when compared to that of COL2A1 (Fig. 3D ). COL10A1 expression was low in comparison with all other genes. No statistical differences were found between time points. To conclude, SFCCs show a cartilage-like phenotype, although Col-1 does remain present. Table S1 ). ns = p > 0.05.
Stimulated SFCCs show cellular and matrix-related changes comparable to those in the early phase of OA
To model the inflammatory environment of OA, SFCCs were treated with IL-1β and TNFα. both of which are considered to be the most important proinflammatory cytokines at the onset of OA. Cytokines were applied with concentrations of 50 ng/ml for IL-1β, and 100 ng/ml for TNFα representing a highly aggressive proinflammatory stimulation in order to achieve maximal effects on the SFCCs. Tissue softening was observed macroscopically by volume increase of SFCCs stimulated for 3 weeks (STIM) compared to untreated controls (CTL) which was partly reversed after 3 additional weeks without cytokine treatment (REG) (Fig. 4A) . This observation was supported by histological H&E staining, microscopically indicating pronounced water retention, maceration of the superficial cell layer and morphological changes in cell phenotypes in the STIM group (Fig. 4B ). Immunohistological analysis showed a constant Col-1 coverage with no statistically significant difference between groups (Fig. 4C ). Col-2 coverage however decreased after stimulation with IL-1β and TNFα to a mean coverage of 14.4 ± 5.5% (STIM)
and moreover significantly to 8.8 ± 5.9% (REG), when compared to the untreated controls (25.3 ± 4.7%; Fig. 4C ). Histomorphometry revealed statistically significant changes between groups in cell count per area for the Tt.A., Ot.A. and outer core area (Ot.C.A.; Fig. 4D ).
Therefore, a lower cell density was observed in the STIM group compared to the CTL, while slight changes were also seen in the REG group compared to CTL. No significant differences were found in the In.C.A. (Fig. 4D) . On the mRNA level, COL1A1 was significantly downregulated upon cytokine stimulation in comparison with the control (Fig. 4E ). The gene expression of COL2A1 and ACAN was obviously lower in the STIM and REG group.
Interestingly, COL10A1 was upregulated in the REG group (Fig. 4E ). As expected, gene expression levels of the inflammatory markers IL1, IL6 and IL8 were significantly upregulated compared to untreated controls (Fig. 4F ). Gene expression of TNF was not found to be different between the experimental groups. However, IL1, IL6 and IL8 were numerically diminished in the REG compared to the STIM group although no statistical significance was detected (Fig.   4F ). MMP1 and MMP3 were significantly upregulated in the cytokine-treated group compared to the CTL group and numerically downregulated in the REG compared to the STIM group ( Fig. 4G ). There were no significant differences in gene expression for MMP13 within the experimental groups. In summary, stimulation with IL-1β and TNFα leads to OA-like changes which can be observed in vivo during the early phase of the disease. Additional cultivation for 3 weeks without cytokines after stimulation did partially reverse those changes. studied via qPCR for IL1, TNF, IL6,  IL8, MMP1, MMP3, MMP13 
Refining an existing mathematical model results in a reduced PDE model of the in vitro observations to simulate the onset of OA
In order to focus on the main processes of cartilage degradation expected during OA onset, the in silico model was built on the assumption that under non-inflammatory conditions, the chondrocytes (termed here as cells) produce ECM (here mainly Col-2) while under inflammatory conditions with the addition of IL-1β, cells release MMPs, which then degrade the ECM, and potentially go into apoptosis (see Figure 1) . Therefore, Table 4 shows the underlying equations derived from the pathway described above and our in vitro observations (adapted from [16] ).
Considering the underlying in vitro experiments and the complexity of the derived in silico model, it was necessary to derive a reduced model preserving our in vitro observations and the underlying biology. The reduced model ( Table 5 ) was obtained as described in the following. For equation (1) , it was possible to distinguish between the decrease due to the matrix formation and due to IL-1β by comparing the reduction of the cell density under noninflammatory and inflammatory conditions in the in vitro models. Thus, we could identify the parameters 1 (non-inflammatory conditions) and 9 (inflammatory conditions) separately.
Following Kar et al., we expected a small increase of Col-2 under non-inflammatory conditions (small value for 2 ) which was negligible compared to the significant decrease induced by the MMPs [16] . Furthermore, we have omitted equation (3) for degCol-2. This component cannot be reliably measured and has no significant impact on other components. MMP measurements are only used for verification ( Fig. 1) , and therefore, parameter 4 and the basal MMP activity p6for which no estimates exist, have been omitted. Finally, in the IL-1β equation (5), the diffusion from outside is certainly the predominant source of IL-1β, which can also be verified In Table 6 , we prescribed the parameter values, initial values and the boundary conditions to solve the PDE system. Concerning the parameter values, the cell apoptosis rate 1 was fitted by a least squares approach, utilizing measurements of the cell concentration (n=3, d= 0, 7, 14, 21). Since the MMP measurements have been neglected up to now, the diffusion coefficient is taken from the literature. The remaining parameters have been calibrated with our in vitro observations. For MMPs, we assumed that there are homogeneous Neumann boundary conditions for all surfaces. Because the evolution of the cell number and Col-2 was described by ODEs, i.e., where no diffusion is present, there exist no boundary conditions for these components. Due to the diffusion of IL-1β into the SFCC with a constant concentration of IL-1β in the surrounding media, inhomogeneous Dirichlet boundary conditions were assumed to be present on the outer surfaces. For the construct's inner surface (center of the cartilage construct), homogeneous Neumann boundary conditions were applied ensuring the symmetry assumption on the SFCC. Constant IL in culture medium and radial symmetry at x=0 (molecular weight of IL is 17kDA)
Modeling the in vitro findings of cytokine-stimulated SFCCs in silico to resemble basic processes of OA cartilage degradation
Since the chondrocytes are inhomogeneously distributed over their space (Fig. 3) , we determined an initial distribution based on the in vitro observations ( Supplementary Fig. S1 ).
Computational results of the in silico model are shown in Figure 5 . The model described in Table 5 makes it possible to represent the in vitro experiments. Under IL-1β stimulation, the cell number decreased over time given the initial distribution (first row of Fig. 5B ), which matches the in vitro measurements (Fig. 4D ). Col-2 decreased spatiotemporally assuming a homogeneous initial distribution (second row in Fig. 5B ). Since IL-1β enters from the outside and stimulated the MMP production, MMPs increased on the boundaries first and diffused further into cartilage (third row in Fig. 5B and Fig. 5C ). Under non-inflammatory conditions, the IL-1β concentration is assumed to be zero. This also holds true for MMP (see Table 5 , equations (3) and (4)). Thus, Col-2 will be constant over time and cells decrease only due to matrix formation leading to a representation of the healthy state observed in vitro as well.
To predict cellular and matrix-related changes over a longer time period (5 weeks) and a 10fold lower concentration of IL-1β stimulation (5 ng/ml)which is more comparable to the in vivo situationwe accordingly adapted the in silico model. We observed a full penetration of IL-1β and MMPs, a fast decline in the cell number, but a rather slower Col-2 degradation when compared to the 3 weeks simulation which had higher IL-1β concentrations (Supplementary video).
MMP staining in the SFCCs verifies in silico simulations
In order to verify the mathematical model, MMP-1 and MMP-13 were stained via immunofluorescence for CTL, STIM and REG sections and analyzed for their spatial distribution and displayed as a sum of that. Therefore, MMP normalization to the cell number was slightly more visible in the STIM group (Fig. 5D ). The relative MMP coverage was lower in the inner core area (In.C.A.) than it was in that of the Ot.C.A. Such a finding applies to a match between the CTL with the STIM groups and also among themselves (Figs. 5E, F) . This also matches the results gained from the in silico model and nicely verifies our approach. Table 5 was solved with the adaptive finite element toolbox KARDOS [25, 26] 
Discussion
Since multiple approaches and a variety of OA model systems are necessary to fully understand the complexity of this disease, we report here on a successful combination of in vitro and in silico modelings to simulate the main features of OA, inflammation and cartilage destruction through upregulation of matrix degrading enzymes. [8] . [28] . In addition, there are some comparable approaches which focus on the production of SFCCs [9, 11, [29] [30] [31] . SFCCs revealed a cartilage-like phenotype detected by gene expression and histological analysis (Fig. 3) ; however, significant differences do remain when those are compared to native human cartilage ( Supplementary Fig. S2 ). Thus, the gene expression of COL1A1 and the presence of Col-1 on a protein level were still visible in all SFCCs examined. hMSCs have the potential to differentiate into different lineages including the chondrogenic, osteogenic and adipogenic lineage, although it has not been yet described that MSCs can fully form human hyaline articular cartilage in vitro or in vivo. Nevertheless, hMSCs are capable to form cartilage-like tissues which have many similarities to in vivo articular cartilage. Since the 3D structure of the SFCCs was gained due to biomechanical loading, the application of transforming growth factor beta (TGF-β) would not have been as beneficial as had been shown previously [32] .
The in vitro simulation of the inflammatory environment in OA through a cytokine treatment with IL-1β at 50 ng/ml and TNFα at 100 ng/ml allowed us to see significant changes in the SFCCs towards an OA phenotype (Fig. 4) (Table   5 ). Validation concerning MMP measurements which were not used to calibrate the model indicates that the reduced in silico model is suited to investigate the influence of different targets for the early phase of OA (Fig. 5 ). In addition, the Supplementary video in this article shows the in silico model's feasibility as a prediction tool for further in vitro experiments. The observed fast decline in the cell number accompanied by a slower Col-2 degradation is in accordance with a previously published study indicating a high chondrocyte death before matrix changes occur [39] . In comparison to the model described by Kar Thus, the simplified model in our study here displays the same features but at the same time involves a smaller number of parameters and uncertainties. Other mathematical simulation approaches for OA and cartilage focus on e.g. poroelastic models or coupling cellular phenotype and mechanics [19, 40, 41] .
In summary, we here describe a human 3D in vitro model of OA based on SFCC which simulates the main features of cartilage destruction, inflammation and upregulation of matrix degrading enzymes. Advantages of such a model include the 3D environment, the possibility for mid-throughput, a sufficient sample volume for several analyses and a wide availability of tissue-engineered cartilage with more scaffold-free approaches emerging. With the combination of in vitro and in silico modeling and close cooperation between biologists and mathematicians, we aim at paving the way towards new, innovative approaches which allow the immediate adaptation and modifications of different models. Within this unique collaboration, we strived to develop a mathematical model to refine and optimize the in vitro model and vice versa, especially regarding the development of a whole joint in vitro/in silico model.
Limitations
The proposed in vitro model displays only one specific part of the disease and includes only one tissue type, although OA has been described as a whole organ disease including several tissues such as the synovial membrane and the subchondral bone. Thus, we are currently working on a more complex whole joint model for both in vitro and in silico aspects. Secondly, biomechanical loading has not yet been addressed within the first in vitro and in silico models presented here, although one's awareness of its tremendous impact has already been published [42] . Thirdly, we shortened the experimental time window by using high concentrations of the proinflammatory cytokines IL-1β and TNFα in our experiments. That bridges the long-lasting cumulative effect of these cytokines over years and decades in the course of OA pathogenesis. Finally, an extension of the in silico model should include the treatment with TNFα due to its playing an important role in OA by describing the disease pathogenesis more accurately. For a profound model validation and parameter fitting, more quantitative in vitro data will be necessary.
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